PDL Biopharma Sues to Protect Cardene I.V.

Law360, New York (April 18, 2007, 12:00 AM EDT) -- An Indian pharmaceutical company has been hit with a patent infringement suit over its efforts to move in on the market for PDL Biopharma Inc.’s hypertension treatment Cardene I.V.

PDL Biopharma filed a lawsuit Tuesday in the U.S. District Court for the Eastern District of Michigan against Sun Pharmaceutical Industries Ltd., which is identified in the complaint as a subsidiary of Mumbai-based “Sun India.”

Also on Tuesday, PDL Biopharma filed a suit looking to enforce the same patent against the same defendant in the U.S. District...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.